AbbVie Inc.: cash_and_restricted_cash
| Value | {"amount": 8759000000, "concept": "us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents", "currency": "USD"} |
|---|---|
| Period | (as of 2023-06-30) |
| Status | current |
| Entity | AbbVie Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T15:44:40.562984+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/35c9b6da-1baa-46c5-8f94-0155194771ee
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001551152-23-000033Retrieved: 2026-08-19T15:44:40.562984+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001551152/cash-and-restricted-cash/2023-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/35c9b6da-1baa-46c5-8f94-0155194771ee
History
- no predecessors — first report